{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Completed",
      "city": "Alameda",
      "state": "CA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "93393",
      "recalling_firm": "Abbott Diabetes Care, Inc.",
      "address_1": "1360 S Loop Rd",
      "address_2": "N/A",
      "postal_code": "94502-7000",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "US Nationwide distribution in the states of NY, CA, NJ, UT, PA, MS, OH, TX, MN, FL, LA, NE, MI, VA, NC, MA, IN, SC, IA.",
      "recall_number": "Z-0734-2024",
      "product_description": "FreeStyle Libre 3 App, part of Continuous Glucose Monitoring System, when used on the Android 13 Operating System",
      "product_quantity": "45,173",
      "reason_for_recall": "If using affected glucose monitoring app on Android 13 Operating System, extended periods of signal loss may be experienced, due to app not connected, which could impact ability to receive glucose reading/alarms, which could lead to undetected low or high glucose, which could result in delayed treatment: not taking insulin (for high glucose), or not taking glucose (for low glucose) when required.",
      "recall_initiation_date": "20230209",
      "center_classification_date": "20240116",
      "report_date": "20240124",
      "code_info": "UDI-DI: 00357599816001, Software v.3.4.0 and below"
    }
  ]
}